Literature DB >> 9502232

Identification of a novel mutation (Leu282Arg) of the human presenilin 1 gene in Alzheimer's disease.

J Aldudo1, M J Bullido, T Arbizu, R Oliva, F Valdivieso.   

Abstract

Many different mutations, causative of Alzheimer's disease, have been found in the presenilin-1 gene (PS-1). We have developed a screening method based on denaturing gradient gel electrophoresis (DGGE), which allows the mutational analysis of the whole exon 9 of PS-1. Upon the screening of a Spanish sample of early onset familial Alzheimer disease cases, we have found a novel mutation in the PS-1 gene. The mutation (a T to G transition) results in a change of the amino acid at position 282 of the presenilin protein from leucine to arginine. This mutation is located in the hydrophobic domain number 7 (exon 9) close to the site of physiological cleavage processing. The average of onset of the affected members of this family is 43+/-5 years, and the average age of exitus of affected members is 56+/-3 years. The possibility to determine the specific pathologic mechanisms of this mutation is now open.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9502232     DOI: 10.1016/s0304-3940(97)00950-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

Review 1.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

2.  A novel presenilin 1 mutation (L282F) in familial Alzheimer's disease.

Authors:  Tsuyoshi Hamaguchi; Akiyoshi Morinaga; Tamao Tsukie; Ryozo Kuwano; Masahito Yamada
Journal:  J Neurol       Date:  2009-05-09       Impact factor: 4.849

3.  Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.

Authors:  D Campion; C Dumanchin; D Hannequin; B Dubois; S Belliard; M Puel; C Thomas-Anterion; A Michon; C Martin; F Charbonnier; G Raux; A Camuzat; C Penet; V Mesnage; M Martinez; F Clerget-Darpoux; A Brice; T Frebourg
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

4.  Structure nor stability of the transmembrane spanning 6/7 domain of presenilin I correlates with pathogenicity.

Authors:  Brian Jeppesen; Laura Costello; Adam Fung; Erin Stanley; Jessica McDonald; Abbie Lambert; Bennett Johnson; Lisa Gentile
Journal:  Biochem Biophys Res Commun       Date:  2007-02-15       Impact factor: 3.575

Review 5.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.